Track cagrilintide in Peptimes™
Cagrilintide is an investigational peptide of 37 amino acids with a fatty-acid chain attached. Novo Nordisk is studying it in clinical trials, including Phase 3 trials. (Source: FDA's substance registry (GSRS).)
Is cagrilintide FDA-approved?
No. Cagrilintide is investigational: it's being studied in clinical trials and isn't FDA-approved for any use.
Cagrilintide
Also: AM833
- Status label in the Peptimes Library
- Phase 3 Trials
- Routes in Peptimes
- Subcutaneous
- Updated
- 1 Nov 2026
US regulatory status
FDA status
Not FDA-approved for any use. Drugs@FDA lists no application with cagrilintide as an active ingredient.
Source: Drugs@FDA, checked 1 Nov 2026
Investigational
Yes.
Source: ClinicalTrials.gov, checked 1 Nov 2026
How to track it in Peptimes
Add cagrilintide in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Phase 3 Trials”, which describes its investigational status. It isn’t an approval.
- Logging: the amount you took and how you feel.
- Injection sites: each dose records the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell cagrilintide or any other compound.
More sources
- NIH, ClinicalTrials.gov, RENEW 4 (NCT07745504), checked 1 Nov 2026: a Phase 3 study of cagrilintide compared with placebo, sponsored by Novo Nordisk, recruiting.
- NIH, ClinicalTrials.gov, studies of cagrilintide, checked 1 Nov 2026: registered studies, all sponsored by Novo Nordisk, including Phase 3 studies.
- FDA, Drugs@FDA, searched 1 Nov 2026: no application lists cagrilintide as an active ingredient.
- FDA, Global Substance Registration System, Cagrilintide, checked 1 Nov 2026: its sequence of 37 amino acids and the attached fatty-acid chain.